Merck & Co., Inc. — Director's Dealing 2018

Nov 1, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2018-10-30

Reporting Person: DeLuca Richard R. (EVP&Pres, Merck Animal Health)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-10-30	Common Stock	M	25467.0000	$34.1900	Acquired	82134.8280	Direct
2018-10-30	Common Stock	S	25467.0000	$72.0045	Disposed	56667.8280	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-10-30	Stock Option (right to buy)	$34.1900	M	25467.0000	Disposed	2021-11-01	Common Stock (25467.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock - 401(k) Plan	1060.3841	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.0000 to $72.0150, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.

F2: Holdings include shares acquired in dividend reinvestment transactions.

F3: Includes shares acquired and dividends earned through October 5, 2018, in the Merck U.S. Savings Plan, a 401(k) plan.

F4: The option became exercisable in equal installments on 11/2/2012, 11/2/2013 and 11/2/2014.